Axsome Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Axsome Therapeutics (AXSM) IPO Opens, Trades Flat
November 19, 2015 12:15 PM ESTToday's IPO for Axsome Therapeutics, Inc. (NASDAQ: AXSM) opened for trading earlier at $9 after pricing 5,666,667 shares of its common stock at a public offering price of $9.00 per share.
Axsome Therapeutics has granted the underwriters a 30-day option to purchase up to an aggregate... More



